La cadena de opciones muestra datos clave de las opciones de acciones de Inspire Veterinary a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Inspire Veterinary..

Inspire Veterinary (NASDAQ:IVP) Bolsa, Cadena de Opciones

Inspire Veterinary

Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.

Movers

Trading Ideas

ARKR

AURA

BLRX

CHEK

CMCT

COEP

IDAI

LINC

MGOL

NINE

RSVR

Conoce las acciones que lideran el premercado tras movimientos clave: Check-Cap sube un 52,2% gracias a nueva patente.

Las acciones de Check-Cap suben un 52%; 20 acciones que se están moviendo antes de la apertura del mercado

Inspire Veterinary Partners, Inc. - Class A Common Stock

Inspire Veterinary Partners Inc

IVANHOE MINES LTD A by Ivanhoe Mines Ltd.

Ivanhoe Mines Ltd

Wellgistics Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGRX#NASDAQ">WGRX</a>), a technology-first pharmaceutical distribution and healthcare infrastructure company, today announced a new initiative to pioneer the use of XRP, a blockchain-based digital asset, as both a treasury reserve and a real-time payments infrastructure-which management believes, upon successful commercialization, would make Wellgistics among the first publicly traded healthcare companies to deploy XRP in this manner.
This XRP payment initiative is supported by Wellgistics Health's $50 million Equity Line of Credit (ELOC), the proceeds of which may be utilized to further develop and unlock programmable liquidity and on-demand financial infrastructure designed to eliminate banking delays, reduce cost, and increase transparency across its national healthcare network.
"At Wellgistics Health, we challenge the idea that healthcare has to be tethered to legacy systems, bloated intermediaries, and slow-moving money," said Brian Norton, CEO of Wellgistics Health. "We are developing a platform that connects manufacturers directly to pharmacies and patients-bypassing the red tape and placing control back in the hands of those who deliver care. Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that's long been starved of all three. I believe that the future winners in healthcare won't be the companies with the biggest buildings…they'll be those with the fastest rails, cleanest data, and most efficient platforms. We're betting on infrastructure…not inertia."

News

Treasuries

WGRX

Wellgistics Health Announces It Has Secured $50M ELOC Facility For XRP Treasury Reserve & Real-Time Payments Infrastructure

Wells Fargo analyst Zachary Fadem maintains Lowe's Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOW#NYSE">LOW</a>) with a Overweight and lowers the price target from $285 to $260.

Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on Lowe's Companies, Lowers Price Target to $260

Baird analyst Mig Dobre maintains Middleby (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIDD#NASDAQ">MIDD</a>) with a Outperform and lowers the price target from $188 to $162.

MIDD

Baird Maintains Outperform on Middleby, Lowers Price Target to $162

To provide necessary funding during the Chapter 11 proceeding, Accelerate has received a commitment of up to $12.5&nbsp;million in a multi-draw DIP financing facility. Upon approval by the Bankruptcy Court, the DIP financing is expected to provide Accelerate with the necessary liquidity to operate in the normal course and meet obligations to its employees, vendors and customers throughout the Chapter 11 proceeding while executing on the sale process.

AXDX

Accelerate Diagnostics Files For Chapter 11 Protection; To Sell Substantially All Assets

Needham analyst Ryan MacDonald reiterates LivePerson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPSN#NASDAQ">LPSN</a>) from Hold to Hold.

Reiteration

LPSN

Needham Reiterates Hold on LivePersonto Hold

WIIM

Kimbell Royalty Partners shares are trading higher after the company reported a Q1 EPS beat.

Groupon Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRPN#NASDAQ">GRPN</a>) shares are trading higher premarket on Thursday. The company reported&nbsp;<a href="https://www.benzinga.com/pressreleases/25/05/45266557/groupon-reports-first-quarter-2025-results">first-quarter&nbsp;financial results</a> after the market closed on Wednesday.
The company reported revenue of&nbsp;$117.2 million, beating estimates of&nbsp;$115.5 million, according to&nbsp;<a target="_blank" href="http://pro.benzinga.com/" rel="noreferrer noopener">Benzinga Pro</a>.
Revenue was down&nbsp;5% (+4% FX-neutral)&nbsp;compared to last year&#8217;s first quarter (Y/Y).
Also Read: <a href="https://www.benzinga.com/25/05/45278823/over-5-million-americans-set-to-lose-health-coverage-by-2034-amid-proposed-gop-medicaid-cuts-cbo-analysis">Over 5 Million Americans Risk Losing Health Coverage By 2034 Amid Proposed GOP Medicaid Cuts, CBO Finds</a>
Groupon reported an&nbsp;EPS of&nbsp;18 cents, versus estimates <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">for a loss of 11 cents</a>.
Gross billings totaled&nbsp;$386.5 million&nbsp;in the&nbsp;first quarter, up 1%&nbsp;Y/Y (+2% Y/Y FX-neutral).
Dusan Senkypl, CEO of Groupon said, &#8220;With North America Local Billings accelerating to double-digit growth and our local marketplace strategy showing green shoots across geographies and verticals, we are building momentum and expect to continue to accelerate our growth.&#8221;
Unit sales were 8.5 million, down 6% year over year, and active customers were 15.5 million as of March 31, down 4% year over year.
Gross profit dipped 4% Y/Y to $106.3 million, and adjusted EBITDA declined to $15.3 million from $19.5 million in the prior year quarter.
Groupon&#8217;s operating cash flow was flat, and free cash outflow was $3.8 million in the quarter.
The company ended the period with&nbsp;$226.8 million in cash and cash equivalents.
Outlook: Groupon expects&nbsp;second-quarter&nbsp;revenue of&nbsp;$121 million&nbsp;to&nbsp;$123 million vs. <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">consensus of $119.66 million</a>.
The company expects&nbsp;second-quarter&nbsp;billings to be up 4%&nbsp;to&nbsp;7%&nbsp;year over year and adjusted EBITDA to be between $14 million and $17 million.
Groupon guided for full-year billings growth <a href="https://s22.q4cdn.com/731250486/files/doc_financials/2025/q1/GRPN-Q1-2025-Earnings-Commentary.pdf" target="_blank" rel="noreferrer noopener">of</a> 3% to 4% (<a href="https://www.benzinga.com/news/earnings/25/03/44263961/groupon-stock-moves-higher-after-q4-earnings-company-says-momentum-has-carried-into-2025">vs. 2%&nbsp;to&nbsp;4% prior</a>), and reaffirms revenue outlook of $493 million to $500 million (vs. street view of $496.96 million).
Price Action: GRPN shares are up 12.2% at $19.06 premarket at the last check on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/45267616" target="_blank" rel="noreferrer noopener">Alibaba Stock Drops After US Lawmakers Push For Delisting</a></li>
</ul>
Photo by Casimiro PT via Shutterstock

Earnings

Equities

Guidance

Small Cap

Tech

GRPN

Groupon Posts Surprize Q1 Profit, Raises Annual Outlook

AXGN

Axxogen shares are trading lower after the company reported a Q1 adjusted EPS miss.

Eco Wave Power Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WAVE#NASDAQ">WAVE</a>) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.11) by 90.91 percent. This is unchanged from the same period last year.

Earnings Beats

WAVE

Eco Wave Power Global Q1 EPS $(0.01) Beats $(0.11) Estimate

Wells Fargo analyst Chris Carey maintains Edgewell Personal Care (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPC#NYSE">EPC</a>) with a Overweight and lowers the price target from $35 to $32.

Wells Fargo Maintains Overweight on Edgewell Personal Care, Lowers Price Target to $32

United-Guardian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UG#NASDAQ">UG</a>) reported quarterly earnings of $0.12 per share. This is a 40 percent decrease over earnings of $0.20 per share from the same period last year. The company reported $2.48 million in sales this quarter. This is a 23.78 percent decrease over sales of $3.25 million the same period last year.

United-Guardian Q1 EPS $0.12 Down From $0.20 YoY, Sales $2.48M Down From $3.25M YoY

Dr. Gordon Downie shares case-based evidence demonstrating how CyPath&#xAE; Lung improves diagnostic confidence and guides care in high-risk patients

Biotech

General

BIAF

bioAffinity Technologies Announces Release Of White Paper Titled "CyPath® Lung in Practice: Cases 1-4,"

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4423150-1&amp;h=3811017285&amp;u=https%3A%2F%2Flucidmotors.com%2F&amp;a=Lucid+Group">Lucid Group</a>, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>), maker of the world's most advanced electric vehicles, today announced the opening of its latest Studio and Service Center location in Rutherford, N.J. The new facility, built to serve the rapidly expanding customer base in New Jersey marks Lucid's 43rd permanent location in North America and 58th location globally.
"New Jersey drivers have increasingly embraced the award-winning performance, range, and design of Lucid and we are delighted to open this expansive new studio and service center for our area customers," said Erwin Raphael, Vice President of Revenue at Lucid. "Our passionate Lucid team members are eager to welcome new and prospective customers and deliver the outstanding experience that our owners have come to expect from Lucid."
The Studio and Service Center, located at 290 Veterans Boulevard in Rutherford, NJ is ideally situated at the juncture of Highways 17 and 3 and designed to serve the company's rapidly growing customer base in New Jersey. The new Rutherford location further expands Lucid's presence in the Tri-State area, in addition to locations in Short Hills in New Jersey, White Plains, Manhattan, Plainview, and Manhasset in New York, and King of Prussia in Pennsylvania.

LCID

Lucid Group Announced the Opening Of Studio And Service Center Location In Rutherford, New Jersey. Marks Lucid's 43rd Permanent Location In North America And 58th Location Globally

MGNI

Magnite shares are trading higher after the company reported better-than-expected Q2 financial results and announced a partnership with ITN to modernize local TV advertising.

Skyworks Solutions Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>) shares are trading lower premarket on Thursday after the company reported second quarter FY25 <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45265398/skyworks-reports-q2-fiscal-2025-results" rel="noreferrer noopener">results after market close on Wednesday</a>.
Revenue of&nbsp;$953.2&nbsp;million beat the consensus of&nbsp;$951.47 million. Adjusted EPS of $1.24 <a href="https://www.benzinga.com/earnings" target="_blank" rel="noreferrer noopener">exceeded the estimates of&nbsp;$1.20</a>.
Skyworks CEO Phil Brace says the company returned over $600 million to shareholders through share repurchases and dividends. That&#8217;s the highest quarterly return ever. 
&#8220;Despite recent market volatility, we remain focused on executing our strategy and supporting our customers across a broad set of markets,&#8221; Brace added.
Dividend: The company declared a cash dividend of 70 cents per share, payable on June 17 to shareholders of record as of May 27.
Q3&nbsp;Outlook:&nbsp;Skyworks expects&nbsp;revenue to be between&nbsp;$920 million&nbsp;and&nbsp;$960 million&nbsp;versus estimates of&nbsp;$921.97 million, according to&nbsp;<a target="_blank" href="http://pro.benzinga.com/" rel="noreferrer noopener">Benzinga Pro</a>.
The company anticipates&nbsp;third-quarter&nbsp;adjusted EPS of&nbsp;$1.24 at the mid-point of the revenue range <a href="https://www.benzinga.com/calendars/guidance">versus estimates of&nbsp;$1.06 per share</a>.
Skyworks expects its mobile business to decline sequentially in the low single digits. CFO Kris Sennesael says this is &#8220;generally consistent&#8221; with typical seasonal patterns. 
Leadership Transition: Skyworks appointed Mark Dentinger as senior vice president and chief financial officer, <a href="https://www.benzinga.com/pressreleases/25/05/b45265489/skyworks-announces-leadership-changes" target="_blank" rel="noreferrer noopener">effective June 2, 2025</a>.
Investors can gain exposure to the stock via&nbsp;Global X Internet of Things ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNSR#NASDAQ">SNSR</a>) and&nbsp;First Trust Nasdaq Semiconductor ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTXL#NASDAQ">FTXL</a>).
Price Action:&nbsp;SWKS shares are down 3.56% at $64.50&nbsp;premarket at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/45235394" target="_blank" rel="noreferrer noopener">Nvidia, Broadcom Lead Fund Manager Buys Even As Semiconductor Sector Cools: Analysts</a></li>
</ul>
This illustration was generated using artificial intelligence via Midjourney.

Large Cap

Management

FTXL

SNSR

SWKS

Skyworks Stock Heads Lower Despite Q2 Profit, Sales Victory

Saga Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGA#NASDAQ">SGA</a>) reported quarterly losses of $(0.25) per share. This is unchanged from the same period last year. The company reported quarterly sales of $24.21 million which beat the analyst consensus estimate of $23.00 million by 5.27 percent. This is a 4.28 percent decrease over sales of $25.29 million the same period last year.

Saga Communications Q1 EPS $(0.25), Same YoY, Sales $24.21M Beat $23.00M Estimate

Wells Fargo analyst Brandon Couillard downgrades Myriad Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYGN#NASDAQ">MYGN</a>) from Overweight to Equal-Weight and lowers the price target from $22 to $6.

Downgrades

MYGN

Wells Fargo Downgrades Myriad Genetics to Equal-Weight, Lowers Price Target to $6

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2025/05/07/final-trades-shake-shack-wynn-resorts-spotify-and-the-iyf.html">Halftime Report Final Trades</a>,&#8221; Joshua Brown, CEO of Ritholtz Wealth Management, said he is bullish on Shake Shack Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHAK#NYSE">SHAK</a>), which reported quarterly earnings last week. The company will open 40 to 50 <a href="https://www.benzinga.com/quote/SHAK/earnings">new company-operated stores this year, he noted.</a>
On May 1, the company reported quarterly adjusted earnings per share of 14 cents, missing the street view of 16 cents. Quarterly sales of $320.90 million (up 10.5%) missed the analyst consensus estimate of $328.08 million.
Jim Lebenthal of Cerity Partners said the international expansion makes Wynn Resorts, Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WYNN#NASDAQ">WYNN</a>) a growth stock.
On the earnings front, Wynn Resorts reported quarterly earnings of $1.07 per share on May 6, which missed the analyst consensus estimate of $1.19 per share. The company also reported quarterly sales of $1.70 billion, which missed the analyst consensus estimate of $1.74 billion.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
Shannon Saccocia, chief investment officer of NB Private Wealth, named iShares U.S. Financials ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYF#NYSE">IYF</a>) as her final trade, saying lack of new regulation is a driver here.
Joseph M. Terranova, senior managing director for Virtus Investment Partners, said Spotify Technology S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) hit another all-time high.
Spotify reported quarterly earnings of $1.13 per share on April 29, missing the analyst consensus estimate of $2.33. However, the company&#8217;s quarterly sales of $4.41 billion (4.19 billion euros), up 15% year over year, beat the analyst consensus estimate of $4.20 billion.
Price Action:
<ul>
<li>Shake Shack shares climbed 3.3% to close at $101.93 on Wednesday.</li>
<li>Wynn Resorts shares rose 0.7% to $84.12 during Wednesday's session.</li>
<li>iShares U.S. Financials ETF rose 0.6% on Wednesday..</li>
<li>Spotify shares climbed 3.8% to settle at $657.10.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45250672/wall-streets-most-accurate-analysts-give-their-take-on-3-industrials-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Industrials Stocks Delivering High-Dividend Yields</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Markets

Media

iShares Dow Jones US Financial Sector Index Fund

SHAK

SPOT

WYNN

Spotify, Shake Shack, Wynn Resorts And More: CNBC's 'Final Trades'

Across the recent three months, 18 analysts have shared their insights on Dutch Bros (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BROS#NYSE">BROS</a>), expressing a variety of opinions spanning from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">8</td>
<td align="right">9</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $81.56, a high estimate of $100.00, and a low estimate of $66.00. Marking an increase of 13.18%, the current average surpasses the previous average price target of $72.06. 
<img src="https://www.benzinga.com/files/images/story/2025/1746709282_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A clear picture of Dutch Bros's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Tarantino</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$72.00</td>
<td>$66.00</td>
</tr>
<tr>
<td>Andrew Charles</td>
<td>TD Securities</td>
<td>Maintains</td>
<td>Buy</td>
<td>$78.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Dennis Geiger</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$80.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Jeffrey Bernstein</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$76.00</td>
<td>$94.00</td>
</tr>
<tr>
<td>David Tarantino</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$66.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Gregory Francfort</td>
<td>Guggenheim</td>
<td>Raises</td>
<td>Buy</td>
<td>$72.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Nick Setyan</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$90.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Agnes Lim</td>
<td>TD Securities</td>
<td>Maintains</td>
<td>Buy</td>
<td>$89.00</td>
<td>$89.00</td>
</tr>
<tr>
<td>Anthony Trainor</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Overweight</td>
<td>$80.00</td>
<td>-</td>
</tr>
<tr>
<td>Brian Harbour</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Overweight</td>
<td>$82.00</td>
<td>-</td>
</tr>
<tr>
<td>Chris O'Cull</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$85.00</td>
<td>$74.00</td>
</tr>
<tr>
<td>John Ivankoe</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$80.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Brian Mullan</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$70.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Chris O'Cull</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$74.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Dennis Geiger</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$90.00</td>
<td>$67.00</td>
</tr>
<tr>
<td>David Tarantino</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$95.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Nick Setyan</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$100.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Andrew Charles</td>
<td>TD Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$89.00</td>
<td>$65.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Dutch Bros. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Dutch Bros compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Dutch Bros's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Dutch Bros's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/BROS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Dutch Bros analyst ratings.</a>
<h2>About Dutch Bros</h2>
Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies and other beverages. The company has two reportable operating segments Company-operated shops and Franchising. It derives maximum revenue from Company operated shops.
<h3>Dutch Bros: A Financial Overview</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Dutch Bros displayed positive results in 3M. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 34.89%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 1.05%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Dutch Bros's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 0.68%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.15%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Dutch Bros's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.75.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BROS

Demystifying Dutch Bros: Insights From 18 Analyst Reviews

STKL

SunOpta shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 sales guidance above estimates. Additionally, the company announced a $25 million share repurchase program.

Press Releases

Samantha A. Ciulla Joins Inspire Veterinary Partners as Director of Business Development

Inspire Veterinary Partners Issues Corporate Update Letter to Shareholders

Inspire Veterinary Partners Engages STNL Advisors for Real Estate Advisory Services

Inspire Veterinary Partners Registers the 'Family Pet Care' Trade Name in Maryland

Inspire Veterinary Partners Signs Exclusive Non-Binding Letter of Intent to Acquire Central Florida Based Animal Hospital

Inspire Veterinary Partners Announces up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Inspire Veterinary Partners Announces Closing of up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Inspire Veterinary Partners Reports Full Year 2024 Financial Results

Inspire Veterinary Partners Announces Attendance at Upcoming Investor Events

Inspire Veterinary Partners Celebrates Record Veterinary Hiring and the Appointment of Lynley Kees to Chief People Officer

Acadia Healthcare Company, Inc. - Common Stock

Acadia Healthcare Co

Ardent Health Partners, Inc. Common Stock

Ardent Health Partners

Auna

Brookdale Senior Living Inc. Common Stock

Brookdale Senior Living

Concentra Group Holdings Parent, Inc. Common Stock

Concentra Group Holdings

Community Health Systems, Inc. Common Stock

Community Health Sys

Encompass Health Corporation Common Stock

Encompass Health

Ensign Group

HCA Healthcare

Joint

National HealthCare Corporation Common Stock

National Healthcare

PACS Group

Select Medical Holdings Corporation Common Stock

Select Medical Hldgs

Surgery Partners

Sonida Senior Living

SunLink Health Systems, Inc. Common Stock

SunLink Health Systems

Tenet Healthcare Corporation Common Stock

Tenet Healthcare

The Oncology Institute, Inc. - Common Stock

Oncology Institute

Universal Health Services, Inc. Common Stock

Comments

Inspire Veterinary

Inspire Veterinary (IVP) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL